Filtros de búsqueda

Lista de obras de Kaarina Kowalec

Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case-control study protocol for dimethyl fumarate-induced lymphopenia

artículo científico publicado en 2017

Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients

artículo científico publicado en 2014

Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis

artículo científico publicado en 2018

Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study

artículo científico publicado en 2017

Discordant diagnostic results due to a hepatitis B virus T123A HBsAg mutant.

artículo científico publicado en 2016

From bugs to brains: The microbiome in neurological health

artículo científico publicado en 2016

Genetic diversity of hepatitis B virus genotypes B6, D and F among circumpolar indigenous individuals

artículo científico publicado en 2012

Increased schizophrenia family history burden and reduced premorbid IQ in treatment-resistant schizophrenia: a Swedish National Register and Genomic Study

scientific article published on 12 November 2019

Mendelian randomization provides no evidence for a causal role in the bidirectional relationship between depression and multiple sclerosis

artículo científico publicado en 2021

Methylation age acceleration does not predict mortality in schizophrenia

scientific article published on 04 June 2019

Prevalence and Risk Factors of Substance Use Disorder in Inflammatory Bowel Disease

scientific article published on 06 February 2020

Suspected autoimmune hepatitis and primary biliary cirrhosis unmasked by interferon-beta in a multiple sclerosis patient.

artículo científico publicado en 2012

The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis.

artículo científico publicado en 2013